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portant tool for their religion and hierar-
chy. The meaning of tattoos in the Western 
world during the past centuries was ambig-
uous and was consistently associated with 
low social status.
 Nowadays, tattooing has become very 
popular in many individuals world-wide. 
The tattoos are black or multicolored and 
can be found all over the body, even as so-
called permanent make-up  [2] . There are 
many tattooed role models like football, 
pop or movie stars which has led to a 
broader cultural acceptance of tattoos. 
Medical complications after tattooing are 
often seen by physicians, but are generally 
unknown to the public. Tattooed individu-
als or people who consider getting a tattoo 
are often unaware of the possible effects on 
their health.
 Colored tattoo inks often contain azo 
pigments that are primarily manufactured 
for other purposes (e.g. the staining of con-
sumer products) with no established his-
tory of safe use in humans. In addition, 
such pigments can be decomposed during 
light exposure into hazardous aromatic 
amines and can be disseminated through-
out the human body  [3] . Many pigments 
and, consequently, the decomposition 
products have been found in the lymph 
nodes  [4–10] . Thus, the tattoo inks, impu-
rities and decomposition products get in 
close contact with the immune system. Al-
though the first regulations regarding tat-
too inks have appeared in some countries, 
hazardous substances can still be detected 
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 Abstract 
 The number of tattooed people has substan-
tially increased in the past years. Surveys in 
different countries reveal this to be up to 
24% of the population. The number of re-
ported adverse reactions after tattooing has 
also increased including infections, granulo-
matous and allergic reactions and tumors. 
However, the case reports do not reflect the 
frequency of adverse reactions. This review 
compares the medically documented ad-
verse reactions published in 1991–2011 with 
the findings of a nation-wide survey that re-
cently revealed the features and health prob-
lems associated with tattoos. To compare 
the data with the survey, the sex of patients 
was reported and the location and color of 
tattoos were evaluated. The results show 
clearly that colored tattoo inks are mainly re-
sponsible for adverse skin reactions and that 
tattoos on the extremities are involved most. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Tattooing is an ancient technique and 
human tattoos have been identified from 
ancient times, dating back even to the 
Stone Age  [1] . In some cultures, e.g. Poly-
nesian tribes, tattooing was always an im-
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 [11–13] . Even if there is a declaration of in-
gredients, contamination by metal parti-
cles which may act as possible antigens can-
not be excluded (e.g. nickel)  [14, 15] .
 Black tattoo inks are frequently neither 
analyzed nor controlled prior to use. Their 
manufacturing process is based on soot, 
and so they contain toxic, mutagenic or 
carcinogenic compounds such as carbon 
black and polycyclic aromatic hydrocar-
bons (PAHs) or phenol  [13] . Furthermore, 
PAHs can absorb UV radiation and gener-
ate cytotoxic singlet oxygen, which might 
affect skin integrity  [13, 16] .
 A survey conducted by Huxley and 
Grogan in 2005  [17]  showed that there 
‘were no significant relationships between 
healthy behaviors, health value and num-
bers of tattoos. A significant proportion of 
tattooed participants had not considered 
possible health risks, others were often 
unaware of potentially serious health 
problems’. People usually assume that 
there are governmental regulations for 
tattoo inks as exist for other products, for 
example, cosmetics. Unfortunately, this is 
not true. Over time, various adverse reac-
tions occurring in connection with tattoos 
have been reported in the medical litera-
ture, mostly as case reports or small-case 
series.
 These case reports describe the adverse 
reaction based on medical examination of 
the respective patients. However, these sin-
gle reports cannot provide an overview on 
the frequency of such adverse reactions. 
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We recently conducted a nation-wide sur-
vey to ascertain the frequency of health 
problems that are associated with tattoos 
 [18] . In this survey, tattooed people were 
asked to report on their health problems. 
The results, however, are based on pre-
defined questions, which were answered by 
medical laypersons.
 We aimed to compare the findings of 
medical reports and the results of the sur-
vey. When reviewing the medical literature 
on tattoo-associated health problems, we 
considered the reports that appeared in 
PubMed between 1991 and 2011, using the 
key words ‘tattoos’, ‘tattooing’ ‘side effects’, 
‘adverse effects’, ‘adverse events’, ‘tattoo re-
action’, ‘health problems’ and the various 
diagnoses in combination with ‘tattoo’.
 Results and Discussion 
 For many years, tattooists used inorgan-
ic pigments that contained heavy metals 
such as mercury, chromium or cadmium. 
Nowadays, the colored tattoo inks mainly 
consist of azo or polycyclic pigments  [19] . 
These pigments comprise two perfect fea-
tures for tattooing: they exhibit brilliant 
colors and are insoluble in aqueous tissue 
( fig. 1 a). The chemistry of black inks, which 
predominantly contain carbon black, has 
not changed considerably. Carbon black is 
a powder that mainly com prises amor-
phous particles of carbon with diameters of 
a few tenths of a nanometer ( fig. 1 b).
 Although they are injected into the hu-
man body, tattoo inks usually fulfil no 
pharmaceutical requirements and contain 
a long list of admixtures and impurities 
 [13] ; a first list of detected substances is 
shown in  table 1 . At present, this list is still 
incomplete and further chemical analysis 
of the tattoo inks on the market is required. 
It is already known that the chemistry of 
colored and black tattoo inks differs; hence 
these inks may contain different admix-
tures and impurities  [13, 19] . Colored pig-
ments (azo dyes and polycyclic com-
pounds) show a complex chemical synthe-
sis containing many byproducts, whereas 
black inks are produced by imperfect com-
bustion of hydrocarbons yielding soot 
mainly containing PAH. Consequently, the 
skin might react differently to colored or 
black ink suspensions.
 In our recently published survey, par-
ticipants reported adverse reactions imme-
diately after tattooing and 4 weeks after-
wards. About 6% of the 3,411 participants 
reported persistent skin problems associ-
ated with their tattoos, which were fre-
quently described as itching, intermittent 
or permanent edema or skin papules. Per-
manent edema could simply represent the 
formation of scars or granulomas. These 
side effects were significantly more fre-
quent in female patients than in males and 
with colored rather than black tattoos  [18] .
 In this review, we included 122 pub-
lications (280 patients) which deal with 
 adverse reactions to decorative tattoos ( ta-
ble 2 ). We assigned the published cases to 
the following categories: granulomatous, 
lichenoid or hypersensitivity allergic reac-
tions (category 1), infections (category 2) 
and tumors (category 3, see  table 1 ). Some 
cases that did not fit into these categories 
are discussed separately. To compare the 
data with the survey, the sex of patients and 
location and the color of tattoos, reported 
in the reviewed case reports were depicted 
and evaluated in  table 3 .
 Category 1:  Granulomatous, Lichenoid 
or Hypersensitivity Allergic Reactions 
 The majority of papers (n = 62) describe 
allergic (often eczematous) and granulo-
matous reactions inside the tattooed skin 
area. As mentioned above, tattoo inks may 
contain various substances which have the 
potential to induce skin reactions. Once 
acute inflammatory changes have resolved, 
delayed reactions can also occur which may 
vary in time of occurrence from days to 
several years after tattoo application. Nu-
merous clinical reports on these delayed re-
actions can be found ( table 2 ).
 A clear classification of the delayed tat-
too reactions according to the clinical ap-
pearance and pathological patterns in the 
reviewed articles proved to be challenging, 
because the clinical manifestations were of-
ten not specific and the histological pat-
terns overlapped. There are several reports 
of allergic tattoo reactions due to hypersen-
sitivity to a tattoo pigment leading to con-
tact or photoallergic dermatitis.
 Various patterns of tattoo reactions 
were histopathologically described, includ-
ing granulomatous, lichenoid  [20, 21] , 
lymphohistiocytic and pseudolymphoma-
tous  [22, 23] . Our classification of the re-
viewed articles is in line with the diagnoses 
given in the publications. Medical exami-
nation of patients was frequently restricted 
to a histopathology examination without 
further test procedures (e.g. allergic test-
ing). Some authors state that of the colored 
inks, red most frequently caused delayed 
tattoo reactions  [24] . This is usually con-
firmed by the fact that the emerging tattoo 
reaction is confined to the red in the tattoo 
 [25] . In the past, red colorants often con-
tained mercury or mercuric sulfide (cinna-
bar), which obviously acted as antigens.
 Histopathological examination of tattoo 
reactions often showed only nonspecific 
granulomatous reactions. What the re-
viewed articles have in common is that 
granulomatous reactions after tattooing 
could be subdivided into 2 main categories: 
sarcoidal granulomas (fig. 2a) and other 
granulomatous reactions, e.g. foreign body 
granulomas. It was striking that the major-
ity of cases, which can be assigned to ec-
a b
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 Fig. 1. Electron microscopy shows that tattoo inks (e.g. black inks,  a ) are usually small 
particles with diameters in the range of 30–100 nm. To produce a tattoo of about 100 cm 2 , 
great amounts of tattoo inks are punctured into skin (carbon black,  b ).  
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
14
5.
19
5 
- 1
0/
21
/2
01
9 
9:
37
:2
3 
AM
 Wenzel/Rittmann/Landthaler/Bäumler
 
Dermatology 2013;226:138–147
DOI: 10.1159/000346943
140
zematous, lichenoid or granulomatous re-
actions were observed in colored tattoos. As 
mentioned above, this fact might be due to 
the chemistry of the colored inks used. In 
view of the various substances in tattoo 
inks, it remains very difficult to find the 
trigger for skin reactions after tattooing. 
Unfortunately, the listing of ingredients is 
usually not available due to a frequent lack 
of regulations.
 Sarcoidal Granulomas.  Sarcoidal gran-
ulomas can occur either as an isolated reac-
tion in tattooed skin or they can represent 
the first ‘visible’ signs of systemic sar-
coidosis. A granulomatous tattoo reaction 
should thus always lead to further clinical 
investigation for underlying sarcoidosis 
 [26] . In the articles reviewed, most of the 
patients with sarcoidal granulomas in their 
tattoos displayed systemic sarcoidosis (n = 
16), only two case-series comprising 8 pa-
tients reported sarcoidal granuloma in tat-
tooed patients without systemic sarcoid-
osis  [27, 28] . In some cases of sarcoidal 
granuloma, which appeared in multicol-
ored tattoos, the skin reaction was confined 
to a single tattoo pigment i.e. red, black or 
blue  [27, 29–34] .
 Other Granulomatous Reactions.  The 
introduction of foreign substances into the 
skin can promote a toxic or an immuno-
logical response and reactions to various 
tattoo pigments have been described  [21, 
35, 36] .  The timing of these delayed-type 
hypersensitivity reactions may vary from 
shortly after the tattoo application up to 
several years later  [37, 38] , and may be trig-
gered by retattooing.
 Comparison to Survey.  The results of the 
survey confirm the case reports, which 
clearly show more frequent skin reactions 
(category 1) to colored tattoos (83.3%) than 
to black tattoos (12.5%). The chemistry of 
color pigments like azo or polycyclic com-
pounds is quite complex and comprises 
Table 1.  Substances detected in tattoo inks
Compounds References Comments
Monoazopigment
Disazodiarylide
Naphthol-AS-pigment
Quinacridone
Dioxazine
Cu-phthalocyanine
Cu/Al-phthalocyanine-BrxCly
[11, 19] pigment in color inks
Mercury
Cadmium
Cobalt
Chrome
[62] colored compounds in inks
Carbon black
Iron
[13, 63, 64] ‘color’ of black, brown inks
Titanium dioxide
Aluminium
[19, 63] used for whitening of inks 
Naphthol-AS
2-Methyl-5-nitroaniline
2-5-Dichloraniline
4-Nitro-toluene
[65] synthesis educts and 
decomposition products of 
azo pigments
PAHs 
Phenol
[13] residue of pyrolysis present 
in black inks
Dibutyl-phthalate
Hexachloro-1,3-butadiene
Metheneamine
Dibenzofuran
Benzophenone
9-Fluorenone
3,6-Dimethyl-1 heptyn-3-ol
1,6-Hexandiole, oleamide
7-Hexyl-2-oxepanone
1,1′Oxybis-2-propanol
Carbitol cellosolve
1,2,3,4-Tetrahydro-1-phenyl-naphthalene
[12] impurities in black inks
a
b
 Fig. 2. Examples of adverse tattoo reac-
tions.  a A male patient developed sarcoidal 
granulomas in a tattoo on the upper arm. 
 b A female patient suffered from allergic 
contact dermatitis with a bacterial super-
infection. 
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Table 2.  Adverse reactions to tattoos
References Number of 
papers and 
patients
Age 
(years)
Comments
Category 1: Allergic, lichenoid or granulomatous reactions
Sarcoidal granuloma [27, 34, 66 – 76] 19, 25 23 – 54 patients with systemic sarcoidosis: n = 16, patients 
without systemic sarcoidosis: n = 8 and an allergic 
cause assumed: n = 1 [27]
Other granuloma [77 – 84] 8, 8 17 – 44 granulomatous reaction resolved after biopsy [80],
granuloma annulare-like tattoo reaction [83],
perforating granulomatous dermatitis reaction [84]
Allergic hypersensitivity 
reactions (eczematous and 
lichenoid reactions)
[14, 15, 21, 25, 
37, 85 – 98]
19, 39 19 – 61 lichenoid tattoo reaction [15, 21, 85, 86, 91 – 93, 96], 
contact dermatitis, positive scratch test [88], contact 
dermatitis to red color, positive patch test [89, 90, 
92], reaction confined to red tattoo ink [25] and 
contact dermatitis to India ink [95]
Pseudolymphoma [20, 22, 23, 
99 – 105]
10, 18 32 – 59 pseudolymphomatous tattoo reaction with lichenoid 
aspect [20]
Other [50, 106 – 112] 6, 6 21 – 47 hypersensitivity vasculitis [106, 107, 110 – 112], 
reaction to red tattoo ink [106] association with red 
tattoo ink is assumed, no microbiological 
examination of the tattoo ink [107], lichen sclerosus 
et atrophicus [108], scleroderma-like reaction 
restricted to red parts of tattoo [109], tattoo-induced 
lymphadenopathy in a patient with multiple tattoos 
[50] 
Category 2: Infections
Viral warts [43, 113 – 116] 5, 5 17 – 37
Molluscum contagiosum [117 – 119] 3, 3 20 – 24
HSV (Herpes compunctorum) [120] 1, 1 30
Hepatitis C [121 – 124] 4, 6 25 – 40 and epidemiologic articles [125, 126]
Inoculation tuberculosis 
(M. tuberculosis complex)
[127 – 129] 3, 4 33 – 40
Inoculation leprosy (M. leprae) [130 – 132] 3, 33 21 – 40
Nontuberculous mycobacteria [44, 133 – 141] 10, 47 20 – 51 often gray color due to dilution with tap water [138], 
7 female patients treated by the same cosmetician 
[141]
CA-MRSA with skin and soft
tissue infections
[142, 143] 2, 44 15 – 42 44 recipients of tattoos from 13 unlicensed tattooists 
in 3 states (Ohio, Kentucky, and Vermont, USA)
Other bacterial infections [144 – 149] 5, 6 18 – 44 toxic shock syndrome [144], ‘necrotizing cutaneous 
reaction’ [145], epidural abscess [146], endocarditis 
[147, 148] and polymicrobial septicemia [149]
Tinea [45] 1, 1 unknown
Leishmaniasis [150] 1, 1 30 visceral leishmaniasis with cutaneous lesions in 
tattoo of an HIV-positive patient
Category 3: Tumors
MM [151 – 158] 8, 8 26 – 56 several case reports of tattoo pigment in sentinel 
lymph node mimicking MM
BCC [54, 159 – 162] 5, 6 35 – 72 2 older ladies from Iran: head tattoo
SCC [163, 164] 2, 3 30 – 47
KA [165 – 168] 4, 11 36 – 66 in 82% of cases association with red tattoo color 
[168]
Other [47, 169 – 172] 4 ,  5 20 – 41 dermatofibrosarcoma protuberans [169, 172], 
cutaneous leiomyosarcoma [170] and ‘autograft 
nevus’ [171]
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many hazardous substances that have the 
potential to provoke adverse skin reactions. 
The high frequency of adverse reactions to 
colored inks is of particular importance, be-
cause colored tattoos comprise about 40% 
of tattoos, less frequent than black tattoos 
(about 60%).  The case reports show more 
frequent problems in males (58.3%) than in 
females (37.5%). This is contrary to the sur-
vey, in which males reported less adverse 
reactions associated with tattoos than fe-
males. On the one hand, this might be due 
to attitudes, with males underplaying prob-
lems with tattoos. On the other hand, the 
number of patients in the case reports of 
category 1 (n = 96) is clearly smaller than in 
the survey (n = 3,411)  [18] .  The survey 
showed that 45.2% of people have tattoos 
on the trunk, 50.8% on the extremities and 
2.7% on the head and neck. When review-
ing the medical reports ( table 3 ), a much 
higher incidence of adverse reactions is re-
ported for the extremities (50.0%) than for 
the trunk (10.4%). In addition, the head as 
a tattoo location is mentioned an above-
average number of times, possibly due to 
the reported cases of reaction to permanent 
make-up. As 30.2% of the adverse reactions 
were not assigned to a specific location, it 
remains difficult to assess these contradic-
tory results.  Some of the substances ( ta-
ble 1 ) in tattoo inks (e.g. PAHs and phtha-
locyanines) are excellent photosensitizers 
that can generate reactive oxygen species 
 [13] in tattooed skin exposed to light. We 
could tentatively speculate that tattoos on 
the head and extremities are more fre-
quently exposed to solar radiation, which 
might be what causes a higher rate of ad-
verse reactions.
 Category 2:  Infections 
 Tattooing entails physical injury of rel-
atively large skin areas that may promote 
the transdermal transmission of viral and 
bacterial infections, depending on the con-
ditions of hygiene during tattooing  [39] . In 
most of the published case reports, insuf-
ficient or a complete lack of sterilization 
procedures in the tattoo parlors was re-
garded as responsible for the transmission 
of infectious diseases. There are 3 potential 
origins of infections after tattooing. Firstly, 
the tattoo ink itself can be contaminated, 
especially by bacterial pathogens .  Second-
ly, in the case of an inadequate disinfection 
of the skin area to be tattooed, residential 
bacteria can enter the skin during the tat-
tooing process. Thirdly, during the healing 
process of the injured tissue after tattoo-
ing, patients often notice pruritus and 
Table 3.  Review of the medical reports listing: sex of patients and tattoo location and color
Patients Sex Location  Color of tattoo ink
number male female un-
known
extremities trunk head un-
known
b lack colored un-
known
Category 1
Allergic reactions 39 25 11 3 14 2 4 19 2 37 0
Sarcoidal granuloma 25 12 12 1 16 2 3 4 9 12 4
Pseudolymphoma 18 11 7 0 11 3 0 4 0 18 0
Nonsarcoidal granuloma 8 4 4 0 4 1 2 1 0 8 0
Other 6 4 2 0 3 2 0 1 1 5 0
Subtotal 96 58.3% 37.5% 4.2% 50.0% 10.4% 9.4% 30.2% 12.5% 83.3% 4.2%
Category 2
Lupus vulgaris 4 1 3 0 4 0 0 0 3 0 1
Leprosy 33 0 33 0 30 1 2 0 0 33 0
Nontuberculous mycobacteria 47 36 11 0 13 1 7 26 13 9 25
CA-MRSA 44 32 12 0 0 0 0 44 0 0 44
Viral warts 5 4 1 0 2 3 0 0 0 3 2
Molluscum contagiosum 3 2 1 0 2 1 0 0 2 1 0
Hepatitis C 6 3 3 0 0 0 3 3 0 0 6
HSV (Herpes compunctorum) 1 1 0 0 0 0 0 1 0 0 1
Tinea 1 0 0 1 0 0 0 1 0 0 1
Leishmaniasis 1 1 0 0 0 0 0 1 0 0 1
Other bacterial infections 6 4 2 0 2 3 0 1 3 1 2
Subtotal 151 55.6% 43.7% 0.7% 35.1% 6.0% 7.9% 51.0% 13.9% 31.1% 55.0%
Category 3
KA 11 8 3 0 10 1 0 0 0 11 0
MM 8 7 1 0 4 3 0 1 4 3 1
BCC 6 3 3 0 1 3 2 0 3 2 1
SCC 3 1 2 0 1 0 1 1 1 1 1
Other 5 5 0 0 5 0 0 0 2 1 2
Subtotal 33 72.7% 27.3% 0% 63.6% 21.2% 9.1% 6.1% 30.3% 54.5% 15.2%
Total 280 58.6% 39.6% 1.8% 43.6% 9.3% 8.6% 38.6% 15.4% 51.8% 32.9%
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burning  [18] , with the risk of superinfect-
ing the tattooed skin area due to scratching 
and therefore inoculating microorganisms 
(fig. 2b).
 Viral Diseases.  According to epidemio-
logical studies and case reports, there is 
strong evidence for the transmission of 
hepatitis B and C virus infections from tat-
tooing ( table 2 ). Tattooing could also, theo-
retically, transmit the human immunodefi-
ciency virus (HIV)  [40–42] , although we 
found no cases of HIV infection in the lit-
erature directly related to tattooing.  Cuta-
neous infections caused by human papil-
lomavirus (HPV) include common, plan-
tar and juvenile warts. Cases of HPV 
infection have been observed due to trans-
mission of the virus during the process of 
tattooing or the presence of HPV in the tat-
too dye. In one case, a 32-year-old man ex-
perienced development of multiple warts 
restricted to the tattooed area after sun-
burn damage. The tattoo had been per-
formed 2.5 years previously, so in this case, 
HPV persisted asymptomatically for a long 
period before activation by local UV-in-
duced immunosuppression resulting in 
multiple warts  [43] . There are also reports 
on the appearance of  Molluscum contagio-
sum caused by  Poxviridae and of Herpes 
simplex virus (HSV) infection in tattooed 
areas, also via transmission during the tat-
tooing process (see category 2, table 2 ).
 Bacterial Infections.  Reported cases on 
bacterial infections related to tattooing 
comprise – among others –  Streptococcus 
pyogenes leading to impetigo, erysipelas 
and even septicemia,  Staphylococcus aure-
us causing the rare toxic shock syndrome, 
skin and soft tissue infections caused by 
community-acquired methicillin-resistant 
 Staphylococcus aureus (CA-MRSA), infec-
tions with atypical mycobacteria and even 
 Mycobacterium leprae which causes lepro-
sy. These bacterial infectious complica-
tions are caused by insufficient personal 
hygiene or lack of hygiene control mea-
sures in the tattooing process. Although 
hygiene in tattoo parlors has improved, of-
ficial inspection is still rare. In recent years, 
several reports of infections with atypical 
mycobacteria after tattooing were pub-
lished  [44] .  A few cases of leprosy after tat-
tooing in India were caused by insufficient-
ly hygienic conditions during the tattooing 
process, which had been performed by 
roadside tattooists.  There was only one re-
port on cutaneous fungal infections in the 
literature reviewed  [45] and a ophthalmo-
logic report of a 40-year-old asplenic man 
with  Candida albicans endophthalmitis of 
the right eye 1 week after tattooing  [46] .
 Comparison to Survey.  The detailed re-
sults of the survey showed that about 0.5% 
of tattooed participants suffered from in-
fections manifesting as pus-filled skin areas 
 [18] . As about 8 million people in Germany 
have tattoos, we estimate that about 40,000 
people would have had bacterial infections 
in the tattooed skin area.  These data fit with 
the high number of reported bacterial in-
fections in the literature ( table 3 ), in par-
ticular when extrapolating this number to 
other countries. The survey showed that 
the person's sex played no role for the risk 
of developing pyogenic bacterial infec-
tions. The case reports in the literature pro-
posed a slightly higher number of male pa-
tients affected by bacterial infections than 
females. Again, tattoos performed on the 
extremities are more frequently involved in 
bacterial infections than those on the trunk. 
Unfortunately, in the literature, location 
was not provided in more than half of the 
cases. When asked about hepatitis, about 
0.6% of the survey participants reported a 
positive test shortly after tattooing, but 
causality cannot be claimed here.
 Category 3:  Tumors 
 The occurrence of benign tumors like 
seborrheic keratosis, histiocytofibroma, epi-
dermal cysts and milia after tattooing is well 
known; cases are only rarely published  [47] .
 Several malignant lesions have oc-
curred in tattoos including basal cell car-
cinoma (BCC), keratoacanthoma (KA), 
squamous cell carcinoma (SCC), malig-
nant melanoma (MM) and dermatofibro-
sarcoma protuberans ( table  2 ). MM has 
been reported to occur in tattoos, vaccina-
tion scars and tattoo sites used for radio-
therapy field marking. To our knowledge, 
there are only 8 documented cases of MM 
after tattooing in the medical literature 
during the years reviewed (1991–2011), but 
there are several case reports on tattoo pig-
ment in sentinel lymph node biopsies 
mimicking MM  [4, 8, 48, 49] . In all these 
cases, the migration of tattoo pigments via 
lymphatic drainage was initially consid-
ered as evidence for metastatic tumors un-
til proper histopathological examination. 
Meanwhile, the transportation of tattoo 
inks, admixtures and impurities from the 
skin to the lymph nodes is a well-known 
fact  [3, 8, 50] . Tattooists often also tattoo 
into pre-existing nevi and pigmented le-
sions, thus impeding a correct clinical and 
dermatoscopic evaluation  [51, 52] .
 BCC has been rarely found to appear af-
ter trauma, for example in surgical scars 
 [53] . This is also the case with KA. Engel et 
al.  [54]  made quite an interesting observa-
tion. They reported an uncommon case of 
BCC of the thumb of a 58-year-old man 
due to an azo-pigment-containing colorant 
repeatedly used as a marker of fishing bait. 
The authors stated that azo pigment in the 
colorants can be cleaved to carcinogenic 
amines under light exposure, in particular 
after incorporation into the human body. 
 In view of the large number of people 
that have tattoos and the few cases of malig-
nant lesions that have been reported so far, 
at present, the association might be coin-
cidental. Numerous factors could be in-
volved, including intradermal injection of 
potentially carcinogenic substances, expo-
sure to UV radiation and genetic factors. 
Recently, high amounts of PAH such as 
benz(a)pyrene were detected in commer-
cially available black tattoo inks  [13] ; these 
obviously enter the skin along with the 
black ink. At the same time, about 10% of 
the participants in our study reported hav-
ing melanocytic nevi within tattooed skin 
areas. Whether the injection of such haz-
ardous substances might affect melanocytic 
nevi is unclear so far and should be deter-
mined by means of epidemiological studies.
 It is to be kept in mind that dark black 
tattoos cannot only impede a correct clini-
cal and dermatoscopic evaluation, but can 
also mask the development of new melano-
cytic lesions or the change of existing nevi. 
Physicians should report all skin tumors 
which they observe in tattooed skin. 
 Comparison to Survey.  Skin cancer as-
sociated with tattooed skin was rarely re-
ported in the survey (0.1%, all male), which 
was equivalent to about 8,000 cases in Ger-
many. The review of medical reports shows 
that 24 patients with tumors in tattooed 
skin were male (24/33). The affected tattoo 
was mainly colored (18/33), which again 
confirms that colored tattoos cause more 
adverse reactions than black tattoos (see 
also category 1,  table 3 ). Again, the extrem-
ities and head (total: 72.9%) were more fre-
quently involved as locations than the 
trunk. Exposure of tattoos to solar radiation 
might also play a role.
 Miscellaneous Cutaneous 
Complications after Tattooing 
 Several articles reported a flare of an 
isomorphic Koebner response after tattoo 
application in patients with active suscep-
tible disease, e.g. psoriasis  [55–57] , lichen 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
14
5.
19
5 
- 1
0/
21
/2
01
9 
9:
37
:2
3 
AM
 Wenzel/Rittmann/Landthaler/Bäumler
 
Dermatology 2013;226:138–147
DOI: 10.1159/000346943
144
planus and vitiligo. Punzi et al.  [56]  report-
ed a 26-year-old male patient who devel-
oped psoriasis plaques in a tattoo 1 week 
after  tattooing by an amateur. Subacute cu-
taneous and discoid lupus erythematosus 
following dermal injury during tattoo 
placement and pyoderma gangrenosum 
have also been described  [58–61] . 
 Although lichen planus lesions can the-
oretically develop in tattooed skin, they are 
difficult to differentiate from the lichenoid 
reactions described above and therefore we 
found no specific report on this diagnosis.
 Conclusions 
 When comparing the results of the sur-
vey with the data of the reviewed case re-
ports, there are some concurring and some 
contradictory results. However, the com-
parisons clearly show that colored tattoo 
pigments more frequently cause skin prob-
lems that are associated with granuloma-
tous, lichenoid or hypersensitivity allergic 
reactions and even skin tumors.
 It is also very interesting that the report-
ed skin problems are clearly more frequent 
for tattoos on the extremities than for those 
on the trunk, even though the frequency of 
tattooing is nearly the same for both loca-
tions. As photosensitizing agents were de-
tected in tattoo inks, the more frequent ex-
posure of the extremities to solar radiation 
might have been a contributing factor.
 The review of published case reports 
show that the cause of the skin reactions 
was mainly investigated by histopathology. 
In the case of allergic or granulomatous re-
actions, in general, no further testing was 
applied to establish what triggered such re-
actions. However, diagnostic procedures to 
prove allergic reactions to tattoo colors re-
main challenging due to the numerous and 
usually unknown substances in the tattoo 
inks. So patch testing, as performed in sev-
eral studies to confirm the diagnosis ‘aller-
gic reaction’, might not be the appropri-
ate approach. Subsequently, many authors 
limit their diagnosis to the histopathologi-
cal pattern (e.g. ‘granulomatous type IV-
reaction’) without a definite clinical diag-
nosis. This reflects the problematic inter-
pretation of the observed ‘patterns’ and 
also hampers effective regulating of the use 
of tattoo inks by legislation. In the case of 
infections, hygiene plays an important role, 
which includes the tattooing practice and 
the purity of the used tattoo inks.
 The most important issue, the possible 
role of tattoo inks in the formation of tu-
mors, is unclear so far. The review retro-
spectively considers the medical reports of 
the past 20 years (1991–2011). In view of 
the latency period for carcinogenesis, this 
time span should be correlated to the tat-
tooing practice in the decades prior to this 
period. Tattooing has become increasingly 
popular in this period and the chemistry of 
tattoo inks has changed. The results may 
change within the next 20 years. It is obvi-
ous that well-known mutagenic or carcino-
genic substances like PAHs and many 
amines should not be present in tattoo inks.
 In the light of these results, in particular 
those regarding colored inks, we urgently 
recommend the regulation of tattoo inks 
that leads to application of inks that do not 
contain hazardous substances. A first step 
would be: the substances that are not al-
lowed to be used in cosmetics on top of the 
skin should certainly not be allowed to en-
ter the skin via the puncturing involved in 
tattoos. 
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